CD8A and neoplasm: Our data showed that the deficiency of TDLNs resulted in the attenuated systemic memory phenotype of CD8+T cells and reduced tumor-specific CD8+T cells induced by the combination therapy, which is consistent with the theory that tumor-reactive lymphocytes exit from the TDLNs.